Thursday, February 02, 2012 by: Ethan A. Huff, staff writer
(NaturalNews) There is still a whole lot of money to be made from pushing human papillomavirus (HPV) vaccines on young people around the world. But in order to accomplish this, the market for the vaccines, which include Merck & Co.’s Gardasil and GlaxoSmithKline’s Cervarix, must be expanded to include males as well as females, which is what is currently taking place in Canada.
CBC News reports that Canada’s National Advisory Committee on Immunization (NACI) has now recommended that HPV vaccines be administered to boys between the ages of nine and 26. The announcement comes just months after a U.S. Centers for Disease Control and Prevention (CDC) committee also recommended that boys get jabbed with the HPV vaccine, despite the fact that nearly 25,000 children have had serious adverse events as a result of the vaccine, and more than 100 have died (http://sanevax.org/).